CH

F. Hoffmann-la Roche Ag

Erasmus+Horizon Europe
www.roche.comCompare
23
Projects
0
Coordinated
24
As Partner
€3,907,573
Total Budget

Budget Range

Min
€16,560
Average
€169,894
Max
€1,486,014

Role Distribution

Sector Distribution

Budget by Sector (€)

Projects (23)

P

Multi-stakeholder Education Alliance to Accelerate Drug Development for Children and Adolescent with Cancer (ALADDIN)

Erasmus+ Alliances101056190
€1,486,014
P

EUROPEAN RARE DISEASES RESEARCH ALLIANCE

HORIZON.2.1101156595
€563,174
P

Research in Europe and Diversity Inclusion

Health101166227
€315,380
P

Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

Health101112135
€230,322
P

GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

Health101112066
€176,610
P

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

Health101172693
€135,248
P

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

Health101218845
€126,000
P

Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare

Health101132847
€103,138
P

A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

Health101136379
€99,993
P

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

Health101112022
€99,425
P

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

HORIZON.2.1101165912
€85,000
P

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models

Health101165643
€84,996
P

Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs 

Health101136365
€61,983
P

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

Health101219311
€51,998
P

CLinical impact through AI-assisted MS care

Health101112153
€47,838
P

Advancing Equity, Diversity and Inclusion in Clinical Trials

MSCA (Marie Skłodowska-Curie)101226601
€43,499
P

From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

MSCA (Marie Skłodowska-Curie)101081481
€37,632
P

Macrocycles for Drug Discovery

MSCA (Marie Skłodowska-Curie)101168916
€32,708
P

Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

Health101163781
€30,387
P

Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

MSCA (Marie Skłodowska-Curie)101119911
€27,185
P

Decoding novel reaction chemistries in biocatalysis – Training Europe’s next visionaries for a sustainable future

MSCA (Marie Skłodowska-Curie)101073065
€26,300
P

Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable

HORIZON.1.2101072632
€26,185
P

The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation

MSCA (Marie Skłodowska-Curie)101182922
€16,560